The Right ETF for Biotech Takeover Targets

The health care sector is often fertile ground for mergers and acquisitions activity and the biotechnology sub-industry is usually the epicenter of both rumors and confirmed deals. Large pharmaceuticals companies looking to bolster pipelines and guard against lost revenue from expiring patents...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.